Therapeutic responses in asthma and COPD: BronchodilatorsDONOHUE, James F.Chest. 2004, Vol 126, Num 2, pp 125S-137S, issn 0012-3692, SUPArticle

Optimum Bronchodilator Combinations in Chronic Obstructive Pulmonary Disease: What is the Current Evidence?MILES, Matthew C; DONOHUE, James F; OHAR, Jill A et al.Drugs (Basel). 2012, Vol 72, Num 3, pp 301-308, issn 0012-6667, 8 p.Article

Safety and Efficacy of β AgonistsDONOHUE, James F.Respiratory care. 2008, Vol 53, Num 5, pp 618-624, issn 0020-1324, 7 p.Conference Paper

Improved Sputum expectoration following a single dose of INS316 in Patients with chronic bronchitisJOHNSON, Fred L; DONOHUE, James F; SHAFFER, Christy L et al.Chest. 2002, Vol 122, Num 6, pp 2021-2029, issn 0012-3692, 9 p.Article

The future of chronic obstructive pulmonary disease treatment-difficulties of and barriers to drug developmentMARTINEZ, Fernando J; DONOHUE, James F; RENNARD, Stephen I et al.Lancet (British edition). 2011, Vol 378, Num 9795, pp 1027-1037, issn 0140-6736, 11 p.Article

Do Symptoms Predict COPD in Smokers?OHAR, Jill A; SADEGHNEJAD, Alireza; MEYERS, Deborah A et al.Chest (American College of Chest Physicians). 2010, Vol 137, Num 6, pp 1345-1353, issn 0012-3692, 9 p.Article

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvementBAUGHMAN, Robert P; DRENT, Marjolein; MÜLLER-QUERNHEIM, Joachim et al.American journal of respiratory and critical care medicine. 2006, Vol 174, Num 7, pp 795-802, issn 1073-449X, 8 p.Article

Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ)HANANIA, Nicola A; MANNINO, David M; JHINGRAN, Priti et al.Respiratory medicine. 2010, Vol 104, Num 8, pp 1160-1170, issn 0954-6111, 11 p.Article

Evaluation of the efficacy and safety of levalbuterol in subjects with COPDDONOHUE, James F; PARSEY, Merdad V; ANDREWS, Charles et al.COPD. Journal of chronic obstructive pulmonary disease. 2006, Vol 3, Num 3, pp 125-132, 8 p.Article

Multi-center study : The biochemical efficacy, safety and tolerability of a new α₁-proteinase inhibitor, zemairaSTOCKS, James M; BRANTLY, Mark; POLLOCK, David et al.COPD. Journal of chronic obstructive pulmonary disease. 2006, Vol 3, Num 1, pp 17-23, 7 p.Article

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPDDONOHUE, James F; ANZUETO, Antonio; BROOKS, Jean et al.Respiratory medicine. 2012, Vol 106, Num 7, pp 970-979, issn 0954-6111, 10 p.Article

Bronchodilator Reversibility in COPDHANANIA, Nicola A; CELLI, Bartolome R; DONOHUE, James F et al.Chest (American College of Chest Physicians). 2011, Vol 140, Num 4, pp 1055-1063, issn 0012-3692, 9 p.Article

Health-related quality of life of persons with sarcoidosisCOX, Christopher E; DONOHUE, James F; BROWN, Cynthia D et al.Chest. 2004, Vol 125, Num 3, pp 997-1004, issn 0012-3692, 8 p.Article

Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus TiotropiumDONOHUE, James F; FOGARTY, Charles; KRAMER, Benjamin et al.American journal of respiratory and critical care medicine. 2010, Vol 182, Num 2, pp 155-162, issn 1073-449X, 8 p.Article

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseRENNARD, Stephen I; FOGARTY, Charles; KORENBLAT, Phillip et al.American journal of respiratory and critical care medicine. 2007, Vol 175, Num 9, pp 926-934, issn 1073-449X, 9 p.Article

Airmax: A multi-dose dry powder inhaler. CommentariesKEATING, Gillian M; FAULDS, Diana; CHRYSTYN, Henry et al.Drugs (Basel). 2002, Vol 62, Num 13, pp 1887-1897, issn 0012-6667, 11 p.Article

The Safety and Efficacy of Arformoterol and Formoterol in COPDHANANIA, Nicola A; DONOHUE, James F; NELSON, Harold et al.COPD (Monticello (Sullivan County, N.Y.)). 2010, Vol 7, Num 1, pp 17-31, issn 1541-2555, 15 p.Article

Comparison of sarcoidosis phenotypes among affected African-American siblingsJUDSON, Marc A; HIRST, Kathryn; NEWMAN, Lee S et al.Chest. 2006, Vol 130, Num 3, pp 855-862, issn 0012-3692, 8 p.Article

Prevalence of Airway Obstruction Assessed by Lung Function QuestionnaireMINTZ, Matthew L; YAWN, Barbara P; PRILLAMAN, Barbara A et al.Mayo Clinic proceedings. 2011, Vol 86, Num 5, pp 375-381, issn 0025-6196, 7 p.Article

Comparison of Levalbuterol and Racemic Albuterol in Hospitalized Patients with Acute Asthma or COPD : A 2-Week, Multicenter, Randomized, Open-Label StudyDONOHUE, James F; HANANIA, Nicola A; CIUBOTARU, Ronald L et al.Clinical therapeutics. 2008, Vol 30, Num THEM, pp 989-1002, issn 0149-2918, 14 p., NSArticle

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolDONOHUE, James F; VAN NOORD, Jan A; BATEMAN, Eric D et al.Chest. 2002, Vol 122, Num 1, pp 47-55, issn 0012-3692Article

Nontuberculous mycobacteria in women, young and oldCHALERMSKULRAT, Worakij; GILBEY, Jack G; DONOHUE, James F et al.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, viii, 675-686 [12 p.]Article

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD : A 13-week multicenter trialCASABURI, Richard; BRIGGS, Dick D; DONOHUE, James F et al.Chest. 2000, Vol 118, Num 5, pp 1294-1302, issn 0012-3692Article